Please assess the completion status of the following clinical trial:

Trial Title: Exparel in Minimally Invasive Cardiac Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged 18-75 years inclusive and American Society of Anesthesiologists physical status 2-4.~* Undergoing minimally invasive cardiac surgery.~* Subjects must be physically and mentally able to participate in the study and complete all study assessments.~* Subjects must be able to give fully informed consent to participate in this study after demonstrating a good understanding of the risks and benefits of the proposed components of thoracotomy and chest tube sites infiltration.~Exclusion Criteria:~* History of hypersensitivity or idiosyncratic reactions to amide-type local anesthetics~* Any subject whose anatomy, or surgical procedure, in the opinion of the Investigator, might preclude the potential successful performance of a thoracotomy and chest tube sites infiltration.~* Any subject who in the opinion of the Investigator, might be harmed or be a poor candidate for participation in the study.~* Any subject, who in the opinion of the Investigator, is on chronic pain medicine, including large doses of nonsteroidal antiinflammatory drugs.~* Subjects who have received any investigational drug within 30 days prior to study drug administration, or planned administration of another investigational product or procedure during their participation in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Exparel infiltration (Type: EXPERIMENTAL): Exparel infiltrated into wound and chest tube sites

Based on this trial design, predict the completion outcome and termination type (if applicable).